We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHC icon
2401
Canterbury Park Holding Corp
CPHC
$81.4M
$323K ﹤0.01%
12,479
-18,068
-59% -$429K
FRPH icon
2402
FRP Holdings
FRPH
$425M
$323K ﹤0.01%
10,688
+2,090
+24% +$60.9K
GES
2403
DELISTED
Guess Inc
GES
$320K ﹤0.01%
18,767
-392
-2% -$8.15K
USNA icon
2404
Usana Health Sciences
USNA
$252M
$320K ﹤0.01%
4,428
+771
+21% +$57.4K
PKE icon
2405
Park Aerospace
PKE
$811M
$319K ﹤0.01%
24,973
+100
+0.4% +$1.23K
SENS icon
2406
Senseonics Holdings Inc
SENS
$409M
$319K ﹤0.01%
15,470
+3,113
+25% +$81.1K
EVOP
2407
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$318K ﹤0.01%
13,529
+276
+2% +$6.29K
ANF icon
2408
Abercrombie & Fitch
ANF
$4.84B
$317K ﹤0.01%
18,731
-570,319
-97% -$15.7M
AGEN
2409
Agenus
AGEN
$315M
$316K ﹤0.01%
8,309
+1,480
+22% +$53.7K
CAL icon
2410
Caleres
CAL
$461M
$315K ﹤0.01%
12,004
-13,605
-53% -$337K
CRAI icon
2411
CRA International
CRAI
$1.07B
$315K ﹤0.01%
3,531
+51
+1% +$4.28K
LAND
2412
Gladstone Land Corp
LAND
$358M
$314K ﹤0.01%
14,150
+205
+1% +$6.19K
SLCA
2413
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$314K ﹤0.01%
27,536
-1,000
-4% -$16.8K
VSTO
2414
DELISTED
Vista Outdoor Inc.
VSTO
$314K ﹤0.01%
11,246
+323
+3% +$11.5K
TILE icon
2415
Interface
TILE
$2.24B
$312K ﹤0.01%
24,888
-16,698
-40% -$221K
UBA
2416
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$310K ﹤0.01%
19,130
+100
+0.5% +$1.73K
AEVA
2417
Aeva Technologies
AEVA
$1.56B
$309K ﹤0.01%
19,716
+3,684
+23% +$60.7K
SVC
2418
Service Properties Trust
SVC
$1.06B
$308K ﹤0.01%
11,768
+1,407
+14% +$48.5K
HA
2419
DELISTED
Hawaiian Holdings, Inc.
HA
$308K ﹤0.01%
21,489
+372
+2% +$6.21K
ZUO
2420
DELISTED
Zuora, Inc.
ZUO
$305K ﹤0.01%
34,116
-76,748
-69% -$853K
GPRO icon
2421
GoPro
GPRO
$117M
$304K ﹤0.01%
55,000
+1,001
+2% +$7.32K
HTLD icon
2422
Heartland Express
HTLD
$979M
$304K ﹤0.01%
+21,828
New +$301K
SRG
2423
Seritage Growth Properties
SRG
$128M
$304K ﹤0.01%
58,391
+598
+1% +$5.33K
MTTR
2424
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$304K ﹤0.01%
83,174
+18,458
+29% +$101K
PCVX icon
2425
Vaxcyte
PCVX
$8.76B
$303K ﹤0.01%
13,928
+1,220
+10% +$28.2K

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.